Clinical Trials Directory

Trials / Completed

CompletedNCT03156270

Treatment Outcome Using Vivaer Stylus to Treat Nasal Airway Obstruction

A Prospective, Non-Randomized Study to Evaluate Treatment Outcome of Nasal Airway Obstruction Using the Aerin Medical Vivaer™ Stylus

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Aerin Medical · Industry
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

This study evaluates subjective and objective measures of treatment outcome after using the Aerin Medical Vivaer™ Stylus to treat nasal obstruction

Detailed description

This is a non-significant risk, prospective, non-randomized study to evaluate subjective and objective measures of nasal obstruction both before and after treatment with the Vivaer Stylus. The Stylus is used to deliver radiofrequency (RF) energy to the nasal valve area to improve symptoms in those diagnosed with nasal airway obstruction.

Conditions

Interventions

TypeNameDescription
DEVICEVivaer StylusStylus used to deliver low-power, temperature-controlled, radiofrequency energy to the tissues of the internal nasal valve area

Timeline

Start date
2017-09-19
Primary completion
2019-07-12
Completion
2019-08-06
First posted
2017-05-17
Last updated
2021-06-16
Results posted
2021-06-16

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03156270. Inclusion in this directory is not an endorsement.